Damora Therapeutics, Inc.
USD32.99
+1.51 (+4.80%)
CEO
Jennifer A. Jarrett
IPO Date
2020-10-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$31.48
Prev. Close
$31.48
Day Low
$31.48
Day High
$34.89
52W Low
$2.45
52W High
$38.33
Market Cap
$2.03B
Volume
0.35M
| 245 |
| $29.98 |
| 7 Jul 2026 | Winslow Garrett | General Counsel | M-Exempt | Disposed | 680 | $0.00 |
| 8 May 2026 | Burkavage Brian | SVP, Finance | Disposed | 312,535 | $32.00 |
| 1 Apr 2026 | Jarrett Jennifer | director, officer: See Remarks | A-Award | Acquired | 500,000 | $0.00 |
| 1 Apr 2026 | Jarrett Jennifer | director, officer: See Remarks | A-Award | Acquired | 1,500,000 | $25.50 |
| 1 Apr 2026 | Jarrett Jennifer | — | Disposed | 0 | $0.00 |
| 25 Mar 2026 | Winslow Garrett | General Counsel | A-Award | Acquired | 250,000 | $23.05 |
| 25 Mar 2026 | Turtle Cameron | director | A-Award | Acquired | 37,313 | $23.05 |
| 25 Mar 2026 | Landsittel Michael | director | A-Award | Acquired | 37,313 | $23.05 |